Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 32
2003 43
2004 45
2005 47
2006 52
2007 58
2008 55
2009 48
2010 50
2011 55
2012 59
2013 60
2014 59
2015 51
2016 70
2017 93
2018 97
2019 93
2020 83
2021 74
Text availability
Article attribute
Article type
Publication date

Search Results

1,062 results
Results by year
Filters applied: . Clear all
Page 1
Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial.
Imel EA, Glorieux FH, Whyte MP, Munns CF, Ward LM, Nilsson O, Simmons JH, Padidela R, Namba N, Cheong HI, Pitukcheewanont P, Sochett E, Högler W, Muroya K, Tanaka H, Gottesman GS, Biggin A, Perwad F, Mao M, Chen CY, Skrinar A, San Martin J, Portale AA. Imel EA, et al. Among authors: tanaka h. Lancet. 2019 Jun 15;393(10189):2416-2427. doi: 10.1016/S0140-6736(19)30654-3. Epub 2019 May 16. Lancet. 2019. PMID: 31104833 Free PMC article. Clinical Trial.
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti-FGF23 Antibody, in Adults With X-Linked Hypophosphatemia: Week 24 Primary Analysis.
Insogna KL, Briot K, Imel EA, Kamenický P, Ruppe MD, Portale AA, Weber T, Pitukcheewanont P, Cheong HI, Jan de Beur S, Imanishi Y, Ito N, Lachmann RH, Tanaka H, Perwad F, Zhang L, Chen CY, Theodore-Oklota C, Mealiffe M, San Martin J, Carpenter TO; AXLES 1 Investigators. Insogna KL, et al. Among authors: tanaka h. J Bone Miner Res. 2018 Aug;33(8):1383-1393. doi: 10.1002/jbmr.3475. Epub 2018 Jun 26. J Bone Miner Res. 2018. PMID: 29947083 Free article. Clinical Trial.
Continued Beneficial Effects of Burosumab in Adults with X-Linked Hypophosphatemia: Results from a 24-Week Treatment Continuation Period After a 24-Week Double-Blind Placebo-Controlled Period.
Portale AA, Carpenter TO, Brandi ML, Briot K, Cheong HI, Cohen-Solal M, Crowley R, Jan De Beur S, Eastell R, Imanishi Y, Imel EA, Ing S, Ito N, Javaid M, Kamenicky P, Keen R, Kubota T, Lachmann R, Perwad F, Pitukcheewanont P, Ralston SH, Takeuchi Y, Tanaka H, Weber TJ, Yoo HW, Zhang L, Theodore-Oklota C, Mealiffe M, San Martin J, Insogna K. Portale AA, et al. Among authors: tanaka h. Calcif Tissue Int. 2019 Sep;105(3):271-284. doi: 10.1007/s00223-019-00568-3. Epub 2019 Jun 4. Calcif Tissue Int. 2019. PMID: 31165191 Clinical Trial.
Overview of muographers.
Tanaka HKM, Oláh L. Tanaka HKM, et al. Philos Trans A Math Phys Eng Sci. 2018 Dec 10;377(2137):20180143. doi: 10.1098/rsta.2018.0143. Philos Trans A Math Phys Eng Sci. 2018. PMID: 30530548 Review.
Japanese volcanoes visualized with muography.
Tanaka HKM. Tanaka HKM. Philos Trans A Math Phys Eng Sci. 2018 Dec 10;377(2137):20180142. doi: 10.1098/rsta.2018.0142. Philos Trans A Math Phys Eng Sci. 2018. PMID: 30530547 Review.
Multimodal imaging of cardiac-calcified amorphous tumor.
Saku K, Tahara N, Takaseya T, Shintani Y, Takagi K, Shojima T, Kurata S, Fujimoto K, Abe T, Fukumoto Y, Tanaka H. Saku K, et al. Among authors: tanaka h. J Nucl Cardiol. 2020 Apr;27(2):682-685. doi: 10.1007/s12350-018-01510-0. Epub 2018 Nov 12. J Nucl Cardiol. 2020. PMID: 30421382
Effect of Alzheimer's disease severity on upper limb function.
Tamaru Y, Tanaka H, Ueda M, Sumino H, Imaoka M, Matsugi A, Nishikawa T, Ishii R, Naito Y. Tamaru Y, et al. Among authors: tanaka h. Psychogeriatrics. 2020 Sep;20(5):802-804. doi: 10.1111/psyg.12585. Epub 2020 Aug 2. Psychogeriatrics. 2020. PMID: 32743858 No abstract available.
1,062 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page